ClinicalTrials.gg
CompletedNCT07752082Updated Aug 7, 2026

The Impact of Intra-Abdominal Pressure on Mortality and Morbidity in Patients Undergoing Open-Heart Surgery

An observational study in Intra-Abdominal Hypertension and Postoperative Complications, sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Bursa Yuksek Ihtisas Training and Research Hospital · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational study evaluated whether increased intra-abdominal pressure, meaning increased pressure inside the abdomen, is associated with postoperative complications and mortality in adults undergoing elective open-heart surgery with cardiopulmonary bypass. Intra-abdominal pressure was measured through the urinary bladder at three time points: after anesthesia induction, after closure of the sternum, and two hours after admission to the intensive care unit. Participants with an intra-abdominal pressure of 12 mmHg or higher at any measurement were compared with those whose pressure remained below 12 mmHg. The study examined postoperative recovery outcomes, including time to extubation, length of stay in the intensive care unit and hospital, postoperative complications, and mortality. It also aimed to identify perioperative factors associated with increased intra-abdominal pressure. No study-specific treatment or intervention was assigned, and all patients received standard perioperative care.

Read the detailed description

This prospective observational cohort study investigated perioperative changes in intra-abdominal pressure in patients undergoing elective open-heart surgery with cardiopulmonary bypass and examined whether increased intra-abdominal pressure was associated with postoperative recovery and adverse clinical outcomes.

Intra-abdominal pressure was assessed indirectly through urinary bladder pressure using a standardized measurement technique. Patients were placed in the supine position, 25 mL of sterile saline was instilled into the bladder, and pressure was recorded at end-expiration after zeroing the pressure transducer at the mid-axillary line. Measurements were obtained after induction of anesthesia, after sternal closure, and two hours after admission to the intensive care unit.

Intra-abdominal hypertension was defined as an intra-abdominal pressure of 12 mmHg or higher at any measurement time point. Patients meeting this definition were compared with patients whose intra-abdominal pressure remained below 12 mmHg at all measurements. Demographic, clinical, hemodynamic, laboratory, surgical, and postoperative data were collected prospectively.

No study-specific treatment or intervention was assigned. Anesthetic management, cardiopulmonary bypass management, fluid therapy, hemodynamic support, and postoperative care were provided according to routine institutional practice. The analyses were designed to evaluate associations between intra-abdominal hypertension and postoperative outcomes and to explore perioperative factors associated with increased intra-abdominal pressure. Because the study was observational, the findings were interpreted as associations rather than evidence of causality

02

Conditions studied

  • Intra-Abdominal Hypertension
  • Postoperative Complications

Keywords

  • Intra-abdominal pressure
  • intra-abdominal hypertension
  • morbidity and mortality
  • cardiopulmonary bypass
03

In context

Intra-Abdominal Hypertension

71 studies on the registry are indexed under Intra-Abdominal Hypertension; 16 are open to participants now.

This study's enrollment of 100 is close to the median of 98 across 36 observational studies indexed under Intra-Abdominal Hypertension.

Browse Intra-Abdominal Hypertension studies →

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital is the lead sponsor of 52 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of consecutive adult patients scheduled for elective open-heart surgery with cardiopulmonary bypass at the Department of Anesthesiology and Reanimation of Bursa Yüksek İhtisas Training and Research Hospital between March 2023 and March 2024. Eligible patients who provided written informed consent were enrolled prospectively. Participants were classified according to whether intra-abdominal hypertension developed during the perioperative period. A total of 100 patients were enrolled, and 98 patients were included in the final comparative analysis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Scheduled for elective open-heart surgery using cardiopulmonary bypass
  • of 40% or higher
  • Provision of written

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Requirement for emergency cardiac surgery
  • Open-heart surgery performed without cardiopulmonary bypass
  • of 35 kg/m² or higher
  • Uncontrolled diabetes mellitus
  • History of urinary bladder or urinary tract surgery
  • Active urinary tract infection
  • Acute or chronic renal failure
  • Neurogenic bladder
  • History or presence of cerebrovascular disease
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Intra-abdominal Hypertension Group

    IAH (+): Patients with an intra-abdominal pressure of ≥12 mmHg at least at one measurement time point.

  • No Intra-abdominal Hypertension Group

    IAH (-): Patients with an intra-abdominal pressure of\<12 mmHg at least at one measurement time point.

06

What researchers measure

Primary outcomes

  1. Number of Participants With Postoperative Complications

    The number and percentage of participants who experienced each prespecified postoperative complication were assessed separately. Complications included arrhythmia, surgical-site infection, pneumonia, acute kidney injury, neurological complications, respiratory distress requiring continuous positive airway pressure, postoperative bleeding, reintubation, and prolonged mechanical ventilation. Outcomes were compared between participants with and without intra-abdominal hypertension.

    Time frame: 1 year

  2. In-Hospital All-Cause Mortality

    The number and percentage of participants who died from any cause during the postoperative hospital stay were assessed and compared between participants with and without intra-abdominal hypertension.

    Time frame: 1 year

Secondary outcomes

  1. Time to Extubation

    Postoperative time from completion of surgery to removal of the endotracheal tube, recorded in hours and compared between participants with and without intra-abdominal hypertension.

    Time frame: From completion of surgery to extubation

  2. Intensive Care Unit Length of Stay

    Duration of postoperative intensive care unit stay, recorded in hours and compared between participants with and without intra-abdominal hypertension.

    Time frame: 4 weeks

Other outcomes

  1. Perioperative Factors Associated With Intra-Abdominal Hypertension

    Associations between intra-abdominal hypertension and prespecified perioperative variables were evaluated. These variables included body mass index, cardiopulmonary bypass duration, aortic cross-clamp duration, fluid balance, central venous pressure, mean arterial pressure, heart rate, oxygen saturation, and blood lactate concentration.

    Time frame: From preoperative assessment to 2 hours after intensive care unit admission

07

Study locations

1 site
  • Bursa Yuksek Ihtisas Research and Education Hospital
    Bursa, Yıldırım 16310, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because no prospective data-sharing plan or dedicated data repository was established for this study. Study findings will be reported in aggregate form in scientific publications

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Mar 2024, 12 months.

Of 20 observational studies under Intra-Abdominal Hypertension, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 26. This study's 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2026
First posted
Aug 7, 2026
StartActual
Mar 2, 2023
Primary completionActual
Mar 2, 2024
CompletionActual
Mar 10, 2024
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07752082
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Responsible party
Ilkay Ceylan (Associate proffesor, Bursa Yuksek Ihtisas Training and Research Hospital) — Principal investigator
First posted
Aug 7, 2026
Start date
Mar 2, 2023
Primary completion
Mar 2, 2024
Completion
Mar 10, 2024
Last update
Aug 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion